Marino, Stram & Associates LLC Novartis Ag Transaction History

Marino, Stram & Associates LLC

$445 Million
Q4 2024

A detailed history of Marino, Stram & Associates LLC transactions in Novartis Ag stock. As of the latest transaction made, Marino, Stram & Associates LLC holds 4,642 shares of NVS stock, worth $489,406. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,642

Previous 4,442 4.5%

Holding current value

$489,406

Previous $510,000 11.57%

% of portfolio

0.1%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$96.78 - $117.18 $19,356 - $23,436	200 Added 4.5%	4,642 $451,000
Q3 2024 Oct 21, 2024	BUY	$106.13 - $120.89 $2,759 - $3,143	26 Added 0.59%	4,442 $510,000
Q2 2024 Jul 18, 2024	SELL	$92.57 - $107.37 $4,535 - $5,261	-49 Reduced 1.1%	4,416 $470,000
Q3 2023 Oct 30, 2023	SELL	$94.73 - $105.13 $16,483 - $18,292	-174 Reduced 3.75%	4,465 $454,000
Q2 2023 Jul 20, 2023	BUY	$92.52 - $104.91 $185 - $209	2 Added 0.04%	4,639 $468,000
Q1 2023 Apr 20, 2023	BUY	$80.03 - $92.81 $2,480 - $2,877	31 Added 0.67%	4,637 $426,000
Q4 2022 Jan 19, 2023	BUY	$75.55 - $92.52 $3,097 - $3,793	41 Added 0.9%	4,606 $0
Q3 2022 Oct 17, 2022	BUY	$74.61 - $87.26 $4,476 - $5,235	60 Added 1.33%	4,565 $347,000
Q2 2022 Jul 15, 2022	BUY	$80.52 - $93.75 $19,807 - $23,062	246 Added 5.78%	4,505 $381,000
Q1 2022 Apr 25, 2022	BUY	$80.11 - $90.62 $11,375 - $12,868	142 Added 3.45%	4,259 $374,000
Q4 2021 Jan 20, 2022	SELL	$79.7 - $88.13 $39,610 - $43,800	-497 Reduced 10.77%	4,117 $360,000
Q3 2021 Oct 14, 2021	BUY	$81.78 - $95.14 $377,332 - $438,975	4,614 New	4,614 $377,000
Q2 2021 Jul 22, 2021	SELL	$85.24 - $94.15 $418,016 - $461,711	-4,904 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$83.5 - $98.47 $250 - $295	3 Added 0.06%	4,904 $419,000
Q4 2020 Jan 19, 2021	BUY	$78.07 - $94.43 $3,981 - $4,815	51 Added 1.05%	4,901 $463,000
Q3 2020 Oct 22, 2020	SELL	$82.14 - $91.0 $24,231 - $26,845	-295 Reduced 5.73%	4,850 $422,000
Q2 2020 Jul 20, 2020	BUY	$80.93 - $91.1 $34,395 - $38,717	425 Added 9.0%	5,145 $449,000
Q1 2020 May 05, 2020	SELL	$70.67 - $99.01 $32,084 - $44,950	-454 Reduced 8.77%	4,720 $389,000
Q4 2019 Jan 31, 2020	SELL	$84.35 - $95.37 $4,639 - $5,245	-55 Reduced 1.05%	5,174 $490,000
Q3 2019 Oct 15, 2019	SELL	$85.54 - $94.26 $1,539 - $1,696	-18 Reduced 0.34%	5,229 $454,000
Q2 2019 Jul 19, 2019	SELL	$75.4 - $92.8 $19,830 - $24,406	-263 Reduced 4.77%	5,247 $479,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $1,054 - $1,206	14 Added 0.25%	5,510 $530,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $147 - $164	2 Added 0.04%	5,496 $472,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $25,102 - $29,036	-375 Reduced 6.39%	5,494 $473,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $1,038 - $1,173	-16 Reduced 0.27%	5,869 $443,000
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $1,759 - $2,103	25 Added 0.43%	5,885 $476,000
Q4 2017 Mar 09, 2018	BUY	$72.33 - $77.64 $423,853 - $454,970	5,860	5,860 $492,000

Others Institutions Holding NVS

# of Institutions

1,462

Shares Held

132M

Call Options Held

1.33M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.

Account

Marino, Stram & Associates LLC Novartis Ag Transaction History